Target intelligence / Profile preview

Broad microbial components

Molecular classification
Other
01

Overview

The term Broad microbial components refers to a diverse group of molecules shared by many microorganisms, often referred to as Pathogen-Associated Molecular Patterns (PAMPs). These include structures such as lipopolysaccharides (LPS) from Gram-negative bacteria, peptidoglycan, flagellin, and microbial nucleic acids (e.g., dsRNA or unmethylated CpG DNA). These components are recognized by the host's innate immune system through Pattern Recognition Receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), to initiate an immune response against infection. In a drug discovery context, this entry is considered incorrect or too broad because it does not represent a single, defined molecular target like a specific enzyme or receptor. Instead, it describes a collective category of microbial products that can trigger various biological pathways. Therapeutic strategies typically focus on the specific host receptors that detect these components or the specific microbial enzymes responsible for their synthesis, rather than the broad components themselves.

Other names
Pathogen-associated molecular patternsPAMPsMicrobial-derived productsMicrobial antigens
02

Mechanism of action

Not applicable as this is a broad category of molecules rather than a specific therapeutic target.

03

Biological functions

Immune responseInnate immunity activationInflammation
04

Disease associations

InfectionSepsisInflammationAutoimmune disease
05

Safety considerations

Systemic inflammatory response syndrome (SIRS)Cytokine stormOff-target immune activation

Beyond the preview

Go deeper on Broad microbial components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad microbial components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call